Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease

SUN Wen-Juan; SUN Yong-Hong

doi:10.7499/j.issn.1008-8830.2209008

PDF(461 KB)

Chinese Journal of Contemporary Pediatrics ›› 2023, Vol. 25 ›› Issue (3) : 250-252. DOI: 10.7499/j.issn.1008-8830.2209008

TOPIC OF KAWASAKI DISEASE

Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease

SUN Wen-Juan, SUN Yong-Hong

Author information +

History +

Abstract

Kawasaki disease (KD), also known as mucocutaneous lymph node syndrome, is a systemic acute vasculitis belonging to autoimmune disease. Up to now, the specific pathogenesis of this disease remains unclear, and it may involve various factors such as immune response, inflammatory response, and vascular endothelial injury caused by the activation of the nuclear factor-kappa B (NF-κB) signaling pathway. In particular, children with KD and cardiac injury tend to have a poor prognosis, and researchers hope to explore the specific pathogenesis of cardiac injury in KD to provide new options for clinical diagnosis and treatment and reduce the incidence rate of this disorder. This article reviews the recent research on the role of the NF-κB signaling pathway in cardiac injury in children with KD, so as to provide a basis for future studies.

Key words

Nuclear factor-κB / Signaling pathway / Kawasaki disease / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

SUN Wen-Juan, SUN Yong-Hong. Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease[J]. Chinese Journal of Contemporary Pediatrics. 2023, 25(3): 250-252 https://doi.org/10.7499/j.issn.1008-8830.2209008

References

1 Wang Y, Wang L, Wen X, et al. NF-κB signaling in skin aging[J]. Mech Ageing Dev, 2019, 184: 111160. PMID: 31634486. DOI: 10.1016/j.mad.2019.111160.
2 Lu X, Chen Q, Liu H, et al. Interplay between non-canonical NF-κB signaling and hepatitis B virus infection[J]. Front Immunol, 2021, 12:730684. PMID: 34659217. PMCID: PMC8511458. DOI: 10.3389/fimmu.2021.730684.
3 Krajka-Ku?niak V, Baer-Dubowska W. Modulation of Nrf2 and NF-κB signaling pathways by naturally occurring compounds in relation to cancer prevention and therapy. Are combinations better than single compounds?[J]. Int J Mol Sci, 2021, 22(15):8223. PMID: 34360990. PMCID: PMC8348704. DOI: 10.3390/ijms22158223.
4 Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduct Target Ther, 2020, 5(1): 209. PMID: 32958760. PMCID: PMC7506548. DOI: 10.1038/s41392-020-00312-6.
5 Korbecki J, Simińska D, G?ssowska-Dobrowolska M, et al. Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-κB activation: a review of the molecular mechanisms[J]. Int J Mol Sci, 2021, 22(19): 10701. PMID: 34639040. PMCID: PMC8509318. DOI: 10.3390/ijms221910701.
6 B?ska P, Norbury LJ. The role of nuclear factor kappa B (NF-κB) in the immune response against parasites[J]. Pathogens, 2022, 11(3): 310. PMID: 35335634. PMCID: PMC8950322. DOI: 10.3390/pathogens11030310.
7 Yao C, Narumiya S. Prostaglandin-cytokine crosstalk in chronic inflammation[J]. Br J Pharmacol, 2019, 176(3): 337-354. PMID: 30381825. PMCID: PMC6329627. DOI: 10.1111/bph.14530.
8 Bartekova M, Radosinska J, Jelemensky M, et al. Role of cytokines and inflammation in heart function during health and disease[J]. Heart Fail Rev, 2018, 23(5): 733-758. PMID: 29862462. DOI: 10.1007/s10741-018-9716-x.
9 Ferrandino F, Grazioli P, Bellavia D, et al. Notch and NF-κB: coach and players of regulatory T-cell response in cancer[J]. Front Immunol, 2018, 9: 2165. PMID: 30364244. PMCID: PMC6193072. DOI: 10.3389/fimmu.2018.02165.
10 Barnabei L, Laplantine E, Mbongo W, et al. NF-κB: at the borders of autoimmunity and inflammation[J].Front Immunol, 2021, 12:716469. PMID: 34434197. PMCID: PMC8381650. DOI: 10.3389/fimmu.2021.716469.
11 Rife E, Gedalia A. Kawasaki disease: an update[J]. Curr Rheumatol Rep, 2020, 22(10): 75. PMID: 32924089. PMCID: PMC7487199. DOI: 10.1007/s11926-020-00941-4.
12 Zinatizadeh MR, Schock B, Chalbatani GM, et al. The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases[J]. Genes Dis, 2021, 8(3): 287-297. PMID: 33997176. PMCID: PMC8093649. DOI: 10.1016/j.gendis.2020.06.005.
13 Armaroli G, Verweyen E, Pretzer C, et al. Monocyte-derived interleukin-1β as the driver of S100A12-induced sterile inflammatory activation of human coronary artery endothelial cells: implications for the pathogenesis of Kawasaki disease[J]. Arthritis Rheumatol, 2019, 71(5): 792-804. PMID: 30447136. DOI: 10.1002/art.40784.
14 Bassiouni W, Ali MAM, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease[J]. FEBS J, 2021, 288(24): 7162-7182. PMID: 33405316. DOI: 10.1111/febs.15701.
15 Stock AT, Jama HA, Hansen JA, et al. TNF and IL-1 play essential but temporally distinct roles in driving cardiac inflammation in a murine model of Kawasaki disease[J]. J Immunol, 2019, 202(11): 3151-3160. PMID: 30996002. DOI: 10.4049/jimmunol.1801593.
16 Tremoulet AH, Jain S, JonePN, et al. Phase I/IIatrial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm[J]. J Pediatr, 2019, 215:107-117.e12. PMID: 31561960. PMCID: PMC6878161. DOI: 10.1016/j.jpeds.2019.07.064.
17 Chen J, Jiang L, Yu XH, et al. Endocan: a key player of cardiovascular disease[J]. Front Cardiovasc Med, 2022, 8:798699. PMID: 35071362. PMCID: PMC8766991. DOI: 10.3389/fcvm.2021.798699.
18 Sakurai Y. Autoimmune aspects of Kawasaki disease[J]. J Investig Allergol Clin Immunol, 2019, 29(4): 251-261. PMID: 30183655. DOI: 10.18176/jiaci.0300.